BMRN

BioMarin Pharmaceutical
D

BMRN

58.105
USD
-0.73
(-1.23%)
مغلق
حجم التداول
98,486
الربح لكل سهم
4
العائد الربحي
-
P/E
22
حجم السوق
11,143,125,015
أصول ذات صلة
ALNY
ALNY
-7.74
(-2.40%)
314.76 USD
E
EXEL
-0.270
(-0.60%)
44.880 USD
GILD
GILD
-4.897
(-4.28%)
109.633 USD
INCY
INCY
-1.740
(-2.47%)
68.590 USD
I
IONS
-0.600
(-1.42%)
41.740 USD
NBIX
NBIX
-1.530
(-1.13%)
133.450 USD
REGN
REGN
8.20
(1.47%)
567.83 USD
R
RGEN
-3.796
(-2.83%)
130.214 USD
S
SRPT
-0.885
(-4.64%)
18.175 USD
المزيد
الأخبار المقالات

العنوان: BioMarin Pharmaceutical

القطاع: Healthcare
الصناعة: Biotechnology
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline oftreatments in development.